DK3517958T3 - Midler og fremgangsmåder til bestemmelse af risikoen for type 1-diabetes med serumproteinbiomarkører - Google Patents
Midler og fremgangsmåder til bestemmelse af risikoen for type 1-diabetes med serumproteinbiomarkører Download PDFInfo
- Publication number
- DK3517958T3 DK3517958T3 DK19160490.9T DK19160490T DK3517958T3 DK 3517958 T3 DK3517958 T3 DK 3517958T3 DK 19160490 T DK19160490 T DK 19160490T DK 3517958 T3 DK3517958 T3 DK 3517958T3
- Authority
- DK
- Denmark
- Prior art keywords
- diabetes
- risk
- measures
- determining
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4713—Plasma globulins, lactoglobulin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/775—Apolipopeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20140186 | 2014-06-18 | ||
| EP15738959.4A EP3158337B1 (en) | 2014-06-18 | 2015-06-18 | Methods for determining risk of type-1 diabetes by serum protein biomarkers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3517958T3 true DK3517958T3 (da) | 2020-10-12 |
Family
ID=53673964
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19160490.9T DK3517958T3 (da) | 2014-06-18 | 2015-06-18 | Midler og fremgangsmåder til bestemmelse af risikoen for type 1-diabetes med serumproteinbiomarkører |
| DK15738959.4T DK3158337T3 (da) | 2014-06-18 | 2015-06-18 | Fremgangsmåder til bestemmelse af risiko for type 1-diabetes ved hjælp af serumproteinbiomarkører |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15738959.4T DK3158337T3 (da) | 2014-06-18 | 2015-06-18 | Fremgangsmåder til bestemmelse af risiko for type 1-diabetes ved hjælp af serumproteinbiomarkører |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10877034B2 (da) |
| EP (2) | EP3158337B1 (da) |
| DK (2) | DK3517958T3 (da) |
| ES (2) | ES2825573T3 (da) |
| HU (1) | HUE052117T2 (da) |
| PL (2) | PL3517958T3 (da) |
| WO (1) | WO2015193552A2 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114113624B (zh) * | 2020-08-28 | 2024-08-16 | 香港城市大学深圳研究院 | 利用免疫球蛋白关联蛋白质组开发疾病标志物的方法及装置 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1840573A1 (en) * | 2006-03-27 | 2007-10-03 | Institut Pasteur | Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections |
| WO2010141469A2 (en) | 2009-06-01 | 2010-12-09 | Case Western Reserve University | Protein biomarkers and therapeutic targets for autoimmune and alloimmune diseases |
| US20120177660A1 (en) * | 2011-01-06 | 2012-07-12 | Georgia Health Sciences University Research Institute, Inc. | Biomarkers and therapeutic targets for type 1 diabetes |
| WO2013106851A2 (en) * | 2012-01-13 | 2013-07-18 | Eastern Virginia Medical School | Syncollin, pancreatic triacylglycerol lipase, and other biomarkers for diabetes |
| WO2014015217A1 (en) * | 2012-07-19 | 2014-01-23 | Vertex Pharmaceuticals Incorporated | Biomarkers for hcv infected patients |
-
2015
- 2015-06-18 PL PL19160490T patent/PL3517958T3/pl unknown
- 2015-06-18 DK DK19160490.9T patent/DK3517958T3/da active
- 2015-06-18 DK DK15738959.4T patent/DK3158337T3/da active
- 2015-06-18 WO PCT/FI2015/050448 patent/WO2015193552A2/en active Application Filing
- 2015-06-18 US US15/319,515 patent/US10877034B2/en active Active
- 2015-06-18 ES ES19160490T patent/ES2825573T3/es active Active
- 2015-06-18 EP EP15738959.4A patent/EP3158337B1/en active Active
- 2015-06-18 HU HUE19160490A patent/HUE052117T2/hu unknown
- 2015-06-18 ES ES15738959T patent/ES2728669T3/es active Active
- 2015-06-18 EP EP19160490.9A patent/EP3517958B1/en active Active
- 2015-06-18 PL PL15738959T patent/PL3158337T3/pl unknown
-
2020
- 2020-11-23 US US17/101,693 patent/US12007391B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3158337B1 (en) | 2019-03-06 |
| PL3517958T3 (pl) | 2021-04-19 |
| PL3158337T3 (pl) | 2019-08-30 |
| US20210080458A1 (en) | 2021-03-18 |
| HUE052117T2 (hu) | 2021-04-28 |
| EP3517958A1 (en) | 2019-07-31 |
| EP3158337A2 (en) | 2017-04-26 |
| US20170160276A1 (en) | 2017-06-08 |
| EP3517958B1 (en) | 2020-08-12 |
| DK3158337T3 (da) | 2019-05-13 |
| ES2728669T3 (es) | 2019-10-28 |
| US12007391B2 (en) | 2024-06-11 |
| ES2825573T3 (es) | 2021-05-17 |
| WO2015193552A2 (en) | 2015-12-23 |
| US10877034B2 (en) | 2020-12-29 |
| WO2015193552A3 (en) | 2016-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL265396A (en) | Methods and compositions for detecting analytes | |
| DK3548652T3 (da) | Fremgangsmåder til proteinanalyse | |
| KR20180084817A (ko) | 항-siglec-9 항체 및 이의 이용 방법 | |
| DK3280441T3 (da) | Anti-sortilin-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3292150T3 (da) | Aktiverbare anti-cd166-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3303394T3 (da) | Anti-ctla-4-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3277717T3 (da) | En hidtil ukendt il33-form, muterede former af il33, antistoffer, assays og fremgangsmåder til anvendelse deraf | |
| DK3350220T3 (da) | Anti-pro/latente-myostatin-antistoffer og anvendelser deraf | |
| DK3185854T3 (da) | Injicerbare opslæmninger og fremgangsmåder til fremstilling og anvendelse af disse | |
| DK3258951T3 (da) | Anti-pvrig antistoffer og fremgangsmåder for anvendelse | |
| DK3227336T3 (da) | Anti-CD79b-antistoffer og fremgangsmåder til anvendelse | |
| SI3138489T1 (sl) | Komplet za določanje koncentracije analita | |
| DK3319612T3 (da) | Oxysteroler og fremgansmåder til anvendelse derfor | |
| DK3129779T3 (da) | Fremgangsmåder og sammensætninger til påvisning af fejlfoldede proteiner | |
| DK3197472T3 (da) | Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri | |
| DK3156503T3 (da) | Mavecancer-biomarkør og detektionsfremgangsmåde | |
| DK3128910T3 (da) | Fremgangsmåde til bestemmelse af tværsnitsarealet og voluminet af et objekt | |
| DK3014279T3 (da) | Fremgangsmåde til bestemmelse af proteinaggregater under anvendelse af overflade-fida | |
| DK3167076T3 (da) | Fremgangsmåder og produkter til kvantificering af RNA-transkriptvarianter | |
| DK3437359T3 (da) | Fremgangsmåder til at styre relative målinger under nærvær af LBT | |
| IL246642A0 (en) | Materials and methods for quantifying pld-1 protein levels | |
| DK3189258T3 (da) | Fremgangsmåde til bestemmelse af nedslidningsgraden af en ventil og apparat til bestemmelse af denne | |
| DK3322985T3 (da) | Anordning til påvisning af fejlfoldede proteiner og fremgangsmåder til anvendelse deraf | |
| DK3748358T3 (da) | Cellebaseret fremgangsmåde til bestemmelse af virkningsgraden af defibrotid | |
| DK3259599T3 (da) | Biomarkører til diagnosticering og prognose af ektatiske hornhindelidelser |